News
The Independent on MSN46m
The real reason two ‘miracle’ Alzheimer’s drugs were rejected for NHS useThe UK’s National Institute for Health and Care Excellence (Nice) has declined to recommend two new Alzheimer’s drugs for ...
The FDA label update boosts GE HealthCare’s Vizamyl to a market advantage despite the emergence of blood-based tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback